Clonal Association of Staphylococcus aureus Causing Bullous Impetigo and the Emergence of New Methicillin-Resistant Clonal Groups in Kansai District in Japan

A molecular epidemiological analysis was performed to reveal the clonal association of Staphylococcus aureus strains isolated from patients with bullous impetigo. Pulsed-field gel electrophoresis with cluster analysis, genetic and phenotypic characterizations, and antimicrobial susceptibility profil...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of infectious diseases Vol. 185; no. 10; pp. 1511 - 1516
Main Authors Yamaguchi, Takayuki, Yokota, Yoshiko, Terajima, Jun, Hayashi, Tetsuya, Aepfelbacher, Martin, Ohara, Masaru, Komatsuzawa, Hitoshi, Watanabe, Haruo, Sugai, Motoyuki
Format Journal Article
LanguageEnglish
Published Chicago, IL The University of Chicago Press 15.05.2002
University of Chicago Press
Oxford University Press
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:A molecular epidemiological analysis was performed to reveal the clonal association of Staphylococcus aureus strains isolated from patients with bullous impetigo. Pulsed-field gel electrophoresis with cluster analysis, genetic and phenotypic characterizations, and antimicrobial susceptibility profiling of 88 S. aureus strains isolated from outpatients at 4 hospitals in the Kansai district in Japan were undertaken. Three distinct clonal groups were identified: 2 of them carried the exfoliative toxin (ET) A gene (eta), and the other carried the ETB gene (etb). The former groups represent 2 eta-positive clonal groups that have not been described previously. All the strains in the more dominant eta-positive clonal group and some of the strains in the etb-positive clonal group were methicillin-resistant S. aureus (MRSA) showing borderline-to-moderate resistance to β-lactams. These MRSA strains appear to be emerging clonal groups that have not been considered in previous epidemiological studies of ET-producing S. aureus in Japan and thus pose a significant threat for future treatment of patients with bullous impetigo and/or staphylococcal scaldedskin syndrome.
Bibliography:istex:476C6B57FFDF565C44011A066F6333B8834B6218
ark:/67375/HXZ-NZBKG8W2-H
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
ISSN:0022-1899
1537-6613
DOI:10.1086/340212